Functionalized thiophene polymer--based biosensors

Functionalized thiophene polymer-based biosensors address the limitations of existing biosensors by enhancing surface area and stability, enabling sensitive and selective analyte detection through covalent binding of biological molecules, thereby improving detection accuracy and integration with electronic systems.

WO2024229358A1PCT designated stage expired Publication Date: 2024-11-07UNIVERSITY OF DELAWARE
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
PCT/US2024/027686
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-03
Filing Date
2024-05-03
Publication Date
2024-11-07

AI Technical Summary

Technical Problem

Existing electrochemical biosensors face challenges with sensitivity, stability, and selectivity, as well as integration with electronic components, limiting their effectiveness in detecting analytes in biological samples.

Method used

The development of functionalized thiophene polymer-based biosensors, specifically using PEDOT or PProDOT with maleimide chemistry, which involves electrodeposition of a functionalized thiophene polymer on an electrode, acid grafting, and immobilization of biological molecules via covalent binding, enhancing surface area, stability, and selectivity for analyte detection.

Benefits of technology

The approach results in stable and sensitive biosensors that can effectively detect analytes by forming complexes with biological molecules, facilitating integration with electronic monitoring systems and improving detection accuracy and reliability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure US2024027686_07112024_PF_FP_ABST
    Figure US2024027686_07112024_PF_FP_ABST
Patent Text Reader

Abstract

The present invention provides a biosensor for detecting an analyte. The biosensor comprises an electrode having a surface coated with a layer of a biological molecule-immobilized functionalized thiophene polymer, which comprises a biological molecule and a functionalized thiophene polymer. The biological molecule is immobilized to the functionalized thiophene polymer via covalent binding and is capable of forming a complex with the analyte. Also provided are a method for preparing the biosensor and a method for detecting an analyte with the biosensor.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] FUNCTIONALIZED THIOPHENE POLYMER-BASED BIOSENSORS

[0002] CROSS-REFERENCE TO RELATED APPLICATION

[0003] This application claims priority to United States Provisional Application No. 63 / 499,768, filed May 3, 2023, and the contents of which are incorporated herein by reference in their entireties for all purposes.

[0004] FIELD OF THE INVENTION

[0005] The invention relates to electrochemical biosensors made of functionalized thiophene polymers and preparation and uses thereof.

[0006] BACKGROUND OF THE INVENTION

[0007] In recent years, electrochemical biosensors have been developed to detect analytes in biological samples based on transducing biochemical events to electrical signals. The previous approaches to sensing have had issues with sensitivity, stability, selectivity, and integration with electronic components. Therefore, there remains a need for stable and sensitive electrochemical biosensors.

[0008] SUMMARY OF THE INVENTION

[0009] The present invention relates to functionalized thiophene polymer-based electrochemical biosensors for detecting an analyte. The inventors have surprisingly discovered a stable and sensitive electrochemical biosensor for detecting an analyte based on coupling between the analyte and a biological molecule immobilized to an electrode coated with a thin film of functionalized PEDOT.

[0010] This invention addresses all of the problems associated with previous electrochemical biosensors by using high surface area, nanometer-thin films (increasing the amount of substance that can be examined, helping selectivity); by using all- covalent, highly-efficient chemistry that is highly effective with integrating into biological components (increasing stability), and uses specific biologically active recognition elements (enhancing selectivity). The maleimide chemistry is particularly flexible and effective and works well when connecting to biological molecules like proteins and peptides. Finally, the mechanism of sensing is based on changes in electrical properties in an ultra-thin layer at the functionalized polymer - target solution interface, making it easy to integrate the technology of the present invention into electronic monitoring systems.

[0011] The present invention provides a method for preparing a biosensor for detecting an analyte. The preparation method comprises (a) electrodepositing a functionalized thiophene polymer on a surface of an electrode, wherein the functionalized thiophene polymer is functionalized poly(3,4-ethylenedioxythiophene) (PEDOT) or functionalized poly(3,4-propylenedioxythiophene) (PProDOT), whereby the surface is coated with the functionalized thiophene polymer; (b) adding an acid to the surface coated with the functionalized thiophene polymer, whereby the surface is coated with an acid-grafted thiophene polymer; and (c) immobilizing a biological molecule to the acid-grafted thiophene polymer via covalent binding, wherein the biological molecule is capable of forming a complex with the analyte, whereby a biosensor is prepared, wherein the biosensor comprises the electrode having the surface coated with a layer of the biological molecule-immobilized functionalized thiophene polymer.

[0012] According to the preparation method, the functionalized thiophene polymer may be PEDOT-maleimide, the acid may be 3-mercaptopropionic acid (3-MPA), and the biological molecule may be immobilized to the PEDOT-maleimide through amidation.

[0013] According to the preparation method, the functionalized thiophene polymer may be PProDOT-maleimide, the acid may be 3-mercaptopropionic acid (3-MPA), and the biological molecule may be immobilized to the PProDOT-maleimide through amidation.

[0014] The preparation method may further comprise treating the surface coated with the acid-grafted thiophene polymer with l-ethyl-3-(3- dimethylaminopropyl)carbodiimide (EDC) and N-hydroxysuccinimide (NHS) between step (b) and step (c).

[0015] According to the preparation method, the biological molecule may be a protein.

[0016] According to the preparation method, the layer may have a thickness of 1-1000 nm.

[0017] According to the preparation method, the surface in step (a) may have a charge density of 1-10 E-2 C / cm2.

[0018] According to the preparation method, the biosensor may be an impedimetric biosensor.

[0019] According to the preparation method, the biosensor may be an organic electrochemical transistor (OECT) biosensor. The OECT biosensor may comprise a gate electrode, a drain electrode, a source electrode, an organic semiconductor channel, and an electrolyte. The electrolyte may connect the gate and channel. The gate electrode may be coated with the layer of the biological molecule-immobilized functionalized thiophene polymer.

[0020] For each preparation method of the present invention, a biosensor prepared according to the preparation method is provided.

[0021] The present invention also provides a biosensor for detecting an analyte. The biosensor comprises an electrode having a surface coated with a layer of a biological molecule-immobilized functionalized thiophene polymer, wherein the biological molecule-immobilized functionalized thiophene polymer comprises a biological molecule and functionalized thiophene polymer, wherein the functionalized thiophene polymer is functionalized poly(3,4-ethylenedioxythiophene) (PEDOT ) or functionalized poly(3,4- propylenedioxythiophene) (PProDOT), wherein the biological molecule is immobilized to the functionalized thiophene polymer via covalent binding and is capable of forming a complex with the analyte.

[0022] In the biosensor, the functionalized thiophene polymer may be PEDOT- maleimide.

[0023] In the biosensor, the functionalized thiophene polymer may be PProDOT- maleimide.

[0024] In the biosensor, the biological molecule may be immobilized to the functionalized thiophene polymer through amidation.

[0025] In the biosensor, the layer may have a thickness of 1-1000 nm.

[0026] The biosensor may be an impedimetric biosensor.

[0027] The biosensor may be an organic electrochemical transistor (OECT) biosensor. The OECT biosensor may comprise a gate electrode, a drain electrode, a source electrode, an organic semiconductor channel, and an electrolyte. The electrolyte may connect the gate and channel. The gate electrode may be coated with the layer of the biological molecule-immobilized functionalized thiophene polymer.

[0028] For each biosensor of the present invention, a method for detecting an analyte in a sample is provided. The detection method comprises (a) contacting the sample with the surface coated with the layer of the biological molecule-immobilized functionalized thiophene polymer in the biosensor; and (b) forming a complex by the analyte and the biological molecule, whereby the analyte is attached to the surface, wherein the attachment of the analyte to the surface indicates the presence of the analyte in the sample. The complex may be formed at a pH of 6.5-7.5. The detection method may further comprise removing the analyte from the surface.

[0029] BRIEF DESCRIPTION OF THE DRAWINGS

[0030] FIG. 1 provides schematic representation of the fabrication process of Protein A- immobilized PEDOT-maleimide-based biosensors.

[0031] FIGS. 2a-d show CV results from each postprocessing steps of samples (a) received the complete postprocessing procedure and (b) absent from the EDC / NHS treatment for fixing dopamine on PEDOT-maleimide. (c) and (d) five consecutive CV scans of samples from (a) and (b) after treated by the dopamine solution. The arrow in (d) represents the sequence of CV scans.

[0032] FIGS. 3a-f show CV and EIS of impedimetric biosensors made based on PEDOT- maleimide electrodeposited at (a, d) 7.75 E-2, (b, e) 3.88E-2, and (c, f) 7.75 E-3 C / cm2.

[0033] FIGS. 4a-h show CV and EIS of a variety of controls, (a, e) PEDOT-based impedimetric biosensor, (b, f) PrA-immobilized biosensor incubated in 0 mg / ml IgG (lxPBS buffer), (c, g) no-PrA-immobilized biosensor incubated in 0 mg / ml IgG (lxPBS buffer), (d, h) Physisorption test on PEDOT-maleimide.

[0034] FIGS. 5a-b show (a) CV and (b) EIS of anti-IgG-immobilized PEDOT-maleimide- based biosensor.

[0035] FIGS. 6a-c show (a) The normalized increments of Ret of PrA-immobilized biosensors treated by PrA solutions at different concentrations after incubated in 1 mg / ml IgG (n = 3). The inset is the applied equivalent circuit model, (b) The calibration line of PrA-immobilized biosensors (by 0.001 mg / ml PrA) on sensing IgG solutions from 0.001 to 1 mg / ml (n = 4). (c) The calibration line of IgG-immobilized biosensors (by 1 mg / ml IgG) on sensing PrA solutions from 0.001 to 1 mg / ml (n = 4). The solid line in (b) and (c) represents the linear fit. The data point in (a), (b), and (c) is mean ± standard deviation.

[0036] FIGS. 7a-b show (a) CV and (b) EIS of the reversibility study on IgG- immobilized PEDOT-maleimide-based biosensor.

[0037] FIGS. 8a-b show (a) XPS survey scans of samples from each postprocessing step. Two frames in (a) indicate the positions of N Is and S 2p signals, (b) The evolution of the sulfur-to-nitrogen atomic ratio during the biosensor fabrication and the final sensing step (n = 2). XPS data of both PrA- and IgG-immobilized biosensors was presented.

[0038] FIGS. 9a-g show SEM images of a serial samples at different biosensor preparation stages, (a) uncoated SPE gold working electrode, (b) pristine and (c) 3- MPA treated PEDOT-maleimide. (d) PrA immobilization and (e) IgG sensing samples opposed to (f) IgG immobilization and (g) PrA sensing samples. The scale bar is 1 pm for all taken photos.

[0039] FIGS. lOa-c shows(a) Output and (b) transfer curves of an OECT biosensor with PEDOT-maleimide as the channel material, (c) schematic description of the OECT devices aiming for functionalizing the PEDOT-maleimide channel for biosensing purpose. D and S stand for drain and source electrodes made of gold and the G represents the gate electrode which is Ag / AgCI here. FIGS, lla-b show transfer curves of PEDOT-maleimide-based OECT biosensors before and after the incubation in lmg / ml IgG solution from (a) without PrA immobilization and (b) with PrA immobilization (VD = -0.6 V). The arrow in (b) guides the direction of the shift after the IgG sensing step.

[0040] FIGS. 12a-b show (a) Schematic description of the OECT devices aiming for functionalizing the PEDOT-maleimide gate terminal for biosensing purposes. D and S stand for drain and source electrodes made of gold and the G represents the gate electrode which is PEDOT-maleimide coated gold, (b) The evolution of the drain current at VG = 1.2 V and VD = -0.1 V after exposing to 0, 0.05, and 1 mg / ml IgG solution.

[0041] DETAILED DESCRIPTION OF THE INVENTION

[0042] The present invention relates to functionalized thiophene polymer-based electrochemical biosensors for detecting an analyte by forming a biological couple with a biological molecule immobilized to the functionalized thiophene polymer in a thin layer on an electrode. The present invention is based on the inventors' discovery of electrochemical biosensors that are easy to functionalize, stable and sensitive and respond to Protein A (PrA) and immunoglobulin G (IgG) using appropriately functionalized thin films of poly(3,4-ethylenedioxythiophene) (PEDOT). The inventors have developed electrochemical biosensors coated with a thin layer of a functionalized thiophene polymer targeting the abundant amine functionalities in biological entities, for example, thiols on cysteine, so that the biosensors are useful for detecting other interesting biological couples.

[0043] The term "biosensor" as used herein refers to a device for detecting an analyte using one or more living organisms or biological molecules, for example, enzymes or antibodies.

[0044] The term "electrochemical biosensor" as used herein refers to a biosensor for detecting an analyte based on an electrical and / or electrochemical changes upon exposure to the analyte.

[0045] The term "analyte" as used herein refers to a chemical compound, a biological molecule or a combination thereof.

[0046] The term "biological molecule" as used herein refers to a substance naturally produced by cells or living organisms or a derivative thereof. A derivative of a biological molecule may be synthesized artificially or produced by cells or living organisms that have been genetically modified. Examples of biological molecules include proteins (e.g., protein A and IgG), nucleic acids (e.g., DNAs and RNAs), lipids and carbohydrates.

[0047] The term "biological couple" as used herein refers to a pair of two biological molecules or a biological molecule and a chemical compound that form a complex via non-covalent bonds under naturally occurring conditions. The present invention provides a biosensor for detecting an analyte. The biosensor comprises an electrode. The electrode has a surface coated with a layer of a biological molecule-immobilized functionalized thiophene polymer. The biological molecule-immobilized functionalized thiophene polymer comprises a biological molecule and a functionalized thiophene polymer. The biological molecule is immobilized to the functionalized thiophene polymer via covalent binding. The biological molecule is capable of forming a complex with the analyte. The biological molecule and the analyte may be a biological couple.

[0048] In the biosensor, the biological molecule may be a protein, for example, protein A or IgG. Where the biological molecule is protein A, the analyte may be IgG. Where the biological molecule is IgG, the analyte may be protein A.

[0049] In the biosensor, the functionalized thiophene polymer may be functionalized poly(3,4-ethylenedioxythiophene) (PEDOT). The functionalized PEDOT may be PEDOT - maleimide. The biological molecule may be immobilized to the functionalized PEDOT (e.g., PEDOT-maleimide) through amidation. In one embodiment of the biosensor, protein A may be immobilized to PEDOT-maleimide through amidation. The analyte may be IgG. In another embodiment of the biosensor, IgG may be immobilized to PEDOT-maleimide through amidation. The analyte may be protein A. Examples of other functionalized PEDOT include PEDOT-acid, PEDOT-N3 (azide), and PEDOT-PBA (boronic acid).

[0050] In the biosensor, the functionalized thiophene polymer may be functionalized poly(3,4-propylenedioxythiophene) (PProDOT). The functionalized PProDOT may be PProDOT-maleimide. The biological molecule may be immobilized to the functionalized PProDOT (e.g., PProDOT-maleimide) through amidation. In one embodiment of the biosensor, protein A may be immobilized to PProDOT-maleimide through amidation. The analyte may be IgG. In another embodiment of the biosensor, IgG may be immobilized to PProDOT-maleimide through amidation. The analyte may be protein A.

[0051] The functionalized thiophene polymer may be acid-functionalized polythiophene.

[0052] In the biosensor, the layer of the biological molecule-immobilized functionalized thiophene polymer may have a thickness of about 1-1,000, 1-500, 1-100, 1-50, 1-40, 1-30, 1-20, 1-10, 5-1,000, 5-500, 5-100, 5-50, 5-40, 5-30, 5-20, 5-15, 5-10, 10- 1,000, 10-500, 10-100, 10-50, 10-40, 10-30 or 10-20 nm.

[0053] The biosensor may be an impedimetric biosensor. The impedimetric biosensor may have an electrode coated with a layer of a biologic molecule-immobilized PEDOT- maleimide or a biologic molecule-immobilized PProDOT-maleimide. In one embodiment, the impedimetric biosensor may have an electrode surface coated with a layer of a protein A-immobilized PEDOT-maleimide or a protein A-immobilized PProDOT- maleimide. The analyte may be IgG. In another embodiment, the impedimetric biosensor may have an electrode surface coated with a layer of an IgG-immobilized PEDOT-maleimide or a protein A-immobilized PProDOT-maleimide. The analyte may be protein A.

[0054] The biosensor may be an organic electrochemical transistor (OECT) biosensor. The OECT biosensor may comprise a gate electrode, a drain electrode, a source electrode, an organic semiconductor channel, and an electrolyte that connects the gate and channel, and the gate electrode may be coated with the layer of the biological molecule-immobilized functionalized thiophene polymer. The gate electrode may be coated with a layer of a biologic molecule-immobilized PEDOT-maleimide or a biologic molecule-immobilized PProDOT-maleimide. In one embodiment, the OECT biosensor may comprise a gate electrode having a surface coated with a layer of a protein A- immobilized PEDOT-maleimide or a protein A-immobilized PProDOT-maleimide. The analyte may be IgG. In another embodiment, the OECT biosensor may comprise a gate electrode having a surface coated with a layer of an IgG-immobilized PEDOT-maleimide or an IgG-immobilized PProDOT-maleimide. The analyte may be protein A.

[0055] The present invention also provides a method for preparing a biosensor for detecting an analyte. The preparation method comprises electrodepositing a functionalized thiophene polymer on a surface of an electrode. The functionalized thiophene polymer may be functionalized poly(3,4-ethylenedioxythiophene) (PEDOT) or functionalized poly(3,4-propylenedioxythiophene) (PProDOT). As a result, the surface is coated with the functionalized thiophene polymer. The preparation also comprises adding an acid to the surface coated with the functionalized thiophene polymer so that the surface is coated with an acid-grafted thiophene polymer. The preparation method further comprises immobilizing a biological molecule to the acid-grafted thiophene polymer via covalent binding. The biological molecule is capable of forming a complex with the analyte. Thereby, a biosensor is prepared. The biosensor comprises the electrode having the surface coated with a layer of the biological molecule-immobilized functionalized thiophene polymer.

[0056] According to the preparation method, the biological molecule may be a protein, for example, protein A (PrA) or IgG. Where the biological molecule is protein A (PrA), the analyte may be IgG. Where the biological molecule is IgG, the analyte may be protein A (PrA). According to the preparation method, the functionalized thiophene polymer may be PEDOT-maleimide, the acid may be 3-mercaptopropionic acid (3-MPA), and the biological molecule may be immobilized to the PEDOT-maleimide through amidation. The preparation method may further comprise treating the surface coated with the acid-grafted thiophene polymer with l-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and N-hydroxysuccinimide (NHS) after adding the acid and before immobilizing the biological molecule.

[0057] According to the preparation method, the functionalized thiophene polymer may be PProDOT-maleimide, the acid may be 3-mercaptopropionic acid (3-MPA), and the biological molecule may be immobilized to the PProDOT-maleimide through amidation. The preparation method may further comprise treating the surface coated with the acid-grafted thiophene polymer with l-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and N-hydroxysuccinimide (NHS) after adding the acid and before immobilizing the biological molecule.

[0058] According to the preparation method, the layer of the biological molecule- immobilized functionalized thiophene polymer may have a thickness of about 1-1,000, 1-500, 1-100, 1-50, 1-40, 1-30, 1-20, 1-10, 5-1,000, 5-500, 5-100, 5-50, 5-40, 5-30, 5-20, 5-15, 5-10, 10-1,000, 10-500, 10-100, 10-50, 10-40, 10-30 or 10-20 nm.

[0059] When the functionalized thiophene polymer is electrodeposited on a surface of the electrode, wherein the surface of the electrode may have a charge density of about 1-10, 5-10, 5-9, 5-8, 5-7, 5-6, 6-10, 6-9, 6-8, 6-7, 7-10, 7-9, 7-8, 8-10, 8-9 or 9-10 E-2 C / cm2.

[0060] According to the preparation method, the biosensor may be an impedimetric biosensor. The impedimetric biosensor may have an electrode coated with a layer of a biologic molecule-immobilized PEDOT-maleimide or a biologic molecule-immobilized PProDOT-maleimide. In one embodiment, the impedimetric biosensor may have an electrode surface coated with a layer of a protein A-immobilized PEDOT-maleimide or a protein A-immobilized PProDOT-maleimide. The analyte may be IgG. In another embodiment, the impedimetric biosensor may have an electrode surface coated with a layer of an IgG-immobilized PEDOT-maleimide or a protein A-immobilized PProDOT- maleimide. The analyte may be protein A.

[0061] According to the preparation method, the biosensor may be an organic electrochemical transistor (OECT) biosensor. The OECT biosensor may comprise a gate electrode, a drain electrode, a source electrode, an organic semiconductor channel, and an electrolyte that connects the gate and channel, and the gate electrode may have a surface coated with the layer of the biological molecule-immobilized functionalized thiophene polymer. The gate electrode may have a surface coated with a layer of a biologic molecule-immobilized PEDOT-maleimide or a biologic molecule-immobilized PProDOT-maleimide. In one embodiment, the OECT biosensor may comprise a gate electrode having a surface coated with a layer of a protein A-immobilized PEDOT- maleimide or a protein A-immobilized PProDOT-maleimide. The analyte may be IgG. In another embodiment, the OECT biosensor may comprise a gate electrode having a surface coated with a layer of an IgG-immobilized PEDOT-maleimide or an IgG- immobilized PProDOT-maleimide. The analyte may be protein A.

[0062] For each preparation method, a biosensor prepared according to the preparation method is provided.

[0063] For each biosensor of the present invention, a method for detecting an analyte in a sample is provided. The detection method comprises contacting the sample with the surface coated with the layer of the biological molecule-immobilized functionalized thiophene polymer in the biosensor of the present invention, and forming a complex by the analyte and the biological molecule. Thereby, the analyte is attached to the surface, and the attachment of the analyte to the surface indicates the presence of the analyte in the sample.

[0064] According to the detection method, the complex may be formed at a pH of about 5-8, 5-7.5, 5-7, 5-6.5, 5-6, 5-5.5, 5.5-8, 5.5-7.5, 5.5-7, 5.5-6.5, 5.5-6, 6-8, 6- 7.5, 6-7, 6-6.5, 6.5-8, 6.5-7.5, 6.5-7, 7-8 or 7.5-8.

[0065] The formation of the complex of the analyte and the biological molecule may be reversible. The detection method may further comprise removing the analyte from the surface.

[0066] The term "about" as used herein when referring to a measurable value such as an amount, a percentage, and the like, is meant to encompass variations of ±20% or ±10%, more preferably ±5%, even more preferably ±1%, and still more preferably ±0.1% from the specified value, as such variations are appropriate.

[0067] Example 1. Functional PEDOT-based Biosensors

[0068] In this study, we have summarized the progress made in creating electrochemical biosensors that respond to Protein A (PrA) and immunoglobulin G (IgG) using appropriately functionalized thin films of poly(3,4-ethylenedioxythiophene) (PEDOT). PrA and IgG form biological complexes with the ratio of one PrA roughly binding to two IgG. In order to ensure the approach and platform used in this project could also be generalized to other interesting biological couples, the abundant amine functionalities in biological entities were targeted rather than other rare candidates, for instance, thiols on cysteine. The recently patented maleimide functionalized 3,4- ethylenedioxythiophene (EDOT-maleimide) monomer was used for this project considering the greatly improved stability as well as the chemical tunability introduced by the maleimide moieties of its polymer form (PEDOT-maleimide).

[0069] Overall, we divided the whole biosensing project into two phases. Regarding the first phase, we decided to leverage cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS), and commercially available screen-printed electrode (SPE) to verify the feasibility of our stepwise postprocessing techniques for endowing the SPE capability to sense target analytes in the sample solution. Then we planned to migrate the well-tested postprocessing techniques to the more sensitive organic electrochemical transistor (OECT) devices which were also fabricated on the commercially available interdigitated electrode (IDE) as the second phase. The fabrication and characterization of IDE-based OECT have been recently published by our group.

[0070] To build the functional impedimetric biosensor, we started off electrodepositing PEDOT-maleimide on the desired current collector at a specific charge density, typically 7.75 E-2 C / cm2. Since electrodes for IDE used in this project are made of gold, SPEs comprising gold working and counter electrodes (C223BT) were chosen for experiments. Then, we took advantage of the maleimide functionalities on PEDOT- maleimide for the click reaction with 3-mercaptopropionic acid (3-MPA). This step was meant to transform the maleimide-functionalized surface to an acid-functionalized surface for the following formation of amide bonds with aptamers which was PrA in this project. For this purpose, l-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and N- Hydroxysuccinimide (NHS) were used together to pretreat the 3-MPA grafted PEDOT- maleimide before transferring PrA buffer solution on the electrode surface for the immobilization through amidation. Once amidation was completed, a PrA-functionalized electrode was obtained and ready to sense IgG. The whole procedure described above is illustrated in FIG. 1. Ferricyanide / ferrocyanide (Fe(CN)63 / 4‘) was used as the redox probe in this work to assist in the investigation of the aptamer immobilization and the following sensing step. EIS and CV were performed at every postprocessing step and sensing step.

[0071] Prior to immobilizing PrA, we verified the proposed postprocessing strategy by attaching dopamine molecules to the PEDOT-maleimide surface. PEDOT-maleimide studied in this section was all electrodeposited at 7.75 E-2 C / cm2. In terms of the postprocessing procedure, except for replacing the aptamer buffer solution with 0.01 M dopamine buffer solution, the rest was kept the same. The above-mentioned (Fe(CN)e3’ / 4‘) redox probe was not used instead 0.1 M KCI was used. As dopamine is redox-active and able to be readily oxidized to dopamine quinone within the potential window of water, the successful deposition of dopamine molecules on the PEDOT-maleimide surface could be corroborated by the alteration of its CV shape, i.e., the emergence of the redox peaks from dopamine moieties. FIG. 2a records the CV evolution of PEDOT- maleimide receiving the complete treatment for covalently binding dopamine. As shown in FIG. 2a, the anticipated redox peaks (EI / 2=0.13 V vs. pseudosilver) showed up after the dopamine solution was applied to the surface (the dash-dot curve) confirming that the proposed postprocessing strategy was effective. Before being exposed to the dopamine solution, there were no comparable redox peaks existing in that probed potential range.

[0072] A simple control without treating PEDOT-maleimide by EDC / NHS was conducted and the CV of this experiment is included in FIG. 2b. Even though a pair of hardly seen peaks was spotted in FIG. 2b but the lower peak intensities (both anodic and cathodic) compared to FIG. 2a implied that the physisorption was the potential reason for the existence of the trace of dopamine left on the surface. In order to confirm this hypothesis, five consecutive CV cycles of dopamine-treated samples from FIGS. 2a and 2b, respectively, are presented in FIGS. 2c and 2d. Five cycles in FIG. 2c almost overlapped each other indicating the strong covalent binding between the electrode and dopamine molecules, while both the anodic and cathodic peaks in FIG. 2d shrunk as the scan proceeded which was interpreted as the desorption of dopamine. In other words, there was negligible or even no covalent binding and mostly from physisorption if acid was not activated by EDC / NHS. This comparison was necessary to prove that the covalent binding was through amidation instead of the exchange reaction between 3- MPA and dopamine as the click reaction could also take place between maleimide and primary amine moieties.

[0073] After validating the postprocessing strategy using dopamine molecules, we began to fabricate the PrA-immobilized impedimetric biosensors and performed the corresponding characterizations. Fe(CN)63 / 4' was added to the electrolyte in this section. In the course of the initial investigation, we realized that the charge density for the electrodeposition, which is directly related to the resultant film thickness on the basis of our previous studies, greatly influenced the sensitivity and quantifiability of the assembled devices. Overlooking this fact led to the failure to demonstrate the functional impedimetric biosensors despite the chemistry having been confirmed. For example, FIGS. 3a and 3d are representative CV and EIS from PrA-immobilized biosensors on the basis of PEDOT-maleimide electrodeposited at 7.75 E-2 C / cm2. This charge density was commonly used in our lab and resulted in one micron-level thick film according to our experience. Despite the fact that the postprocessing went well, in FIG. 3d, there were no signs of the semi-circle which is usually used in impedimetric biosensors for quantifying the results of the aptamer immobilization and the following sensing. Briefly, the aptamer immobilization and the following sensing step cause the change of the charge transfer resistance depending on the isoelectric points (PI) of anchored proteins. For EIS, the extent of the charge transfer resistance is usually reflected in the size of the semi-circle in the high-frequency regime of the Nyquist plot (showing the imaginary component of the impedance on the y-axis, and the real component on the x-axis). Herein, by tracking the change of the semi-circle, the number of proteins binding on the surface could be quantified. For CV, the change of the charge transfer resistance also imposes an influence on the peak intensities and peak-to-peak difference of the redox peaks of used redox probes, in this case, Fe(CN)63 / 4‘. FIG. 3a exhibited the decrease of peak intensities and the increase of peak-to-peak difference which was a clear sign of the success of both PrA immobilization and IgG sensing. The conclusion drawn from FIG. 3a followed our expectations as the chemistry has been verified before but the EIS from the same sample was not quantifiable for some reason. Since the postprocessing procedure seemed to work well, we surmised that it was because the PEDOT-maleimide coating was too thick to be impacted impedimetric-wise by the change in the surface chemistry rendered by the postprocessing. Hence, two lower charge densities, 3.88 E-2, and 7.75 E-3 C / cm2were determined carefully to attempt to sort out this question.

[0074] Resembling samples made at 7.75 E-2 C / cm2, the representative CV and EIS of samples obtained at 3.88 E-2 C / cm2receiving the same treatments are in FIGS. 3b and 3e. Similar to FIG. 3a, the gradually dropped peak intensities and widened peak-to- peak difference corroborated that the designated postprocessing procedure already took place, but this charge density was still too high to make usable biosensors in accordance with FIG. 3e. Therefore, we went still further lower, like one-tenth of the initial test, 7.75 E-3 C / cm2. Applying our empirical equation (Subramanian et aL, Macromolecules 2021, 54 (14), 6956-6967), a thickness around 177 nm was estimated to be achieved at this charge density. This thickness is actually close to the thickness of the active materials in reported biosensors, ~ 100 nm. Again, the collected CV and EIS data of biosensors fabricated at this charge density are shown in FIGS. 3c and 3f. CV obtained this time also followed our expectation (FIG. 3f) same as FIGS. 3a and 3b, but the peak intensities decreased more significantly and the widest peak-to-peak difference was spotted here. Finally, at this charge density, its EIS (FIG. 3f) presented clearly not only the targeted semi-circles in each curve but also the gradually expanded semi-circles. According to the above discussion regarding the charge transfer resistance, this discovery suggested that the charge transfer resistance increased along with the postprocessing proceeding. Especially, when the IgG sensing step took place, the green curve (IgG sensing) possessed a larger semi-circle than the blue curve (PrA immobilization), which was in agreement with our assumption. The EIS data of biosensors fabricated on PEDOT-maleimide electrodeposited at 7.75 E-3 C / cm2became quantifiable associated with the proper equivalent circuit model through the model fitting and the following data analysis, which was unfolded somewhere below. Hereinafter, this charge density was used for fabricating functional and quantifiable impedimetric biosensors as well as their controls in this project but not including samples for XPS characterization.

[0075] After the successful fabrication and characterization of PEDOT-maleimide-based impedimetric biosensors, a variety of controls were done to verify the accuracy and reproducibility of the proposed postprocessing mechanism (FIG. 1). In order to stress the indispensability of the maleimide functionality towards achieving the functional biosensor, PEDOT, rather than PEDOT-maleimide, was electrodeposited at 7.75 E-3 C / cm2and experienced the same treatments as its counterpart. The same electrochemical characterization techniques were used, and the representative data is visualized in FIGS. 4a and 4e. In contrast to CV scans in FIG. 3, CV scans in FIG. 4a were almost overlapped except for a negligible displacement after 3-MPA treatment, which could be an instrumental error from one to the other measurement. The same unchanged trend was also extended to its EIS data, FIG. 4e, where all four barely changed diffusion lines were existent. This unimpacted CV and EIS data confirmed that the introduced maleimide functionality was the responsible reactive handle for having the functional biosensor. Without it, the surface did not have the desired bifunctionalities.

[0076] As we have demonstrated the responsive PrA-immobilized biosensor in the existence of IgG at 1 mg / ml (FIGS. 3c and 3f), another test in studying the effect of the buffer solution on the sensing result was implemented. This trial was designated to emphasize that anchoring IgG through the protein-protein interaction with immobilized PrA was responsible for changes observed in FIGS. 3c and 3f. Therefore, other than replacing 1 mg / ml IgG with lxPBS buffer solution, which was the buffer used to dissolve proteins in this project, the rest of the postprocessing procedure remained the same. FIG. 4b presented similar CV changes as FIG. 3c before the sensing step suggesting the successful immobilization of PrA. After incubation in lxPBS, the CV curve (green) only changed slightly rather than dropped significantly as seen in FIG. 3c. So, it was noted that the used buffer solution in this project did not contribute to the change of electrochemical properties of biosensors after incubation in IgG solutions. The same conclusion could also be drawn from the EIS data, FIG. 4f, where the semicircle in the high-frequency range diminished after being treated by lxPBS (green), which was presumably due to the desorption of a portion of PrA bound non-covalently. On the contrary, the same biosensor manifested a larger semi-circle after being treated with 1 mg / ml IgG (FIG. 3f). Thus, the above-observed sensing response of biosensors mainly came from the formed complex between immobilized PrA and free IgG from the solution.

[0077] For justifying the impact of immobilizing PrA on the PEDOT-maleimide surface, lx PBS was used solely for both immobilization and sensing steps. It was noticed that lxPBS did not pose any changes to the CV scan according to FIG. 4c. The corresponding EIS data, FIG. 4g, revealed the decreasing trend of the size of the semicircle after two back-to-back lx PBS incubation in comparison to the increasing trend shown in FIGS. 3f and 4f. On account of this, the change in CV and EIS in the wake of the PrA incubation was the direct consequence of the PrA immobilization rather than the buffer solution effect. The last control we did was concerning the physisorption effect of PEDOT-maleimide or the necessity of acidifying the surface using 3-MPA. For this purpose, we simply incubated pristine PEDOT-maleimide into PrA and IgG solution in sequence. CV and EIS of each step are compiled into FIGS. 4d and 4h. In both figures, measurements after PrA and IgG incubation were barely changed indicating the minimal impact from the protein physisorption. This could again corroborate that the observed alterations in CV and EIS were from the covalently immobilized PrA, i.e., amidation as we proposed. Also, the acidification by fixing 3-MPA through the click reaction with PEDOT-maleimide was needed for the biosensor fabrication. From this point, we have demonstrated that every step of the biosensor fabrication was not redundant and the whole process followed the proposed mechanism illustrated in FIG. 1.

[0078] To gain further insight into the ability to generalize the PEDOT-maleimide platform and the processing protocol, anti-IgG was used in the replacement of PrA, which could also form the biological complex with IgG. Apart from that, the rest of the postprocessing and test were the same as the PrA immobilization. As shown in FIG. 5a, the anti-IgG immobilization did not cause a significant peak current decrease, instead a negligible increase was noticed. The relatively high PI value of anti-IgG (6.5-7.5) was ascribed to this phenomenon, in contrast to PrA (4.9-5.1), as the pH of the electrolyte used in this study was ~6.5. Therefore, as opposed to PrA, the net charge of anti-IgG was either neutral or positive, which supposedly posed less electrostatic repulsion to Fe(CN)63 / 4-during redox reactions, so, less resistive to charge transfer. Consequently, the size of the semi-circle was smaller after the anti-IgG immobilization in FIG. 5b. The subsequent IgG binding slightly lowered the peak intensity and widened the peak-to- peak difference in CV (FIG. 5a) as well as expanded the semi-circle in the high- frequency regime in EIS (FIG. 5b). These findings confirm the successful deposition of IgG on the anti-IgG decorated electrode surface. The result of this experiment strengthened our confidence in using this platform and the postprocessing protocol for other biological couples.

[0079] As in the research of Qi and coworkers on fabricating PrA-coated biosensors on bare gold electrodes relying on weak physisorption (Qi et al., Microchim Acta 2010, 170 (1), 33-38), we realized the significance of the PrA concentration in determining the sensitivity of the final device. PrA solutions at four different concentrations (0.001, 0.01, 0.1, 1 mg / ml) were prepared and used at the PrA immobilization step. 1 mg / ml IgG was used throughout all sensing tests in this investigation and the quantified sensitivities were compared laterally. Since low PrA concentration was used (especially for 0.001 mg / ml), an extra incubation step in 1 mg / ml bovine serum albumin (BSA) solution was introduced before sensing IgG for blocking non-specific binding sites on the electrode. For quantifying the sensitivity of impedimetric biosensors achieved under different PrA concentrations, we applied equivalent circuit model fitting (FIG. 6a inset) on their EIS results and extracted the charge transfer resistance (Ret) before and after being exposed to 1 mg / ml IgG. The normalized increment of Ret in 1 mg / ml IgG as a function of the PrA concentration used for immobilization is plotted in FIG. 6a. It was found that the highest value (0.36 ± 0.06) or the highest sensitivity was obtained on biosensors processed by 0.001 mg / ml PrA solution. Thus, this concentration was later adopted for constructing the calibration line of PrA-immobilized biosensors targeting IgG. Moreover, with respect to the chosen equivalent circuit model, Rs represents the sum of solution resistance, electrode material resistance, and contact resistance. CPE simulates the non-ideal double-layer capacitance and W is the semi-infinite Warburg element selected for simulating the 45° ion diffusion line observed in all Nyquist plots in this project.

[0080] IgG solutions ranging from 0.001 to 1 mg / ml were prepared as known- concentration samples for constructing the calibration line of the PrA-immobilized biosensor for future reference purposes. The same model fitting was performed on the collected EIS data and the normalized increment for each IgG concentration is summarized in FIG. 6b. After performing the linear fit, a positive linearity between the normalized Ret and the IgG concentration was realized. This confirmed that we have successfully fabricated the responsive PrA-immobilized biosensor which reacted not only to the existence of IgG but also the difference in its concentrations. Moreover, we did another verification experiment by switching the processing order of IgG and PrA, i.e., fixing IgG on PEDOT-maleimide-coated electrodes to sense free PrA. Because the solubility of IgG is up to 50 mg / ml in contrast to 1 mg / ml of PrA, 1 mg / ml IgG was decided for the immobilization step. BSA was not necessary for this experiment as only 0.03 Ret increment was derived probably due to the application of high IgG concentration, which was also observed when 1 mg / ml PrA was used for the immobilization step (data not included here). Besides, the pH of the testing electrolyte was changed to 9 from 6.5. The calibration line of IgG-immobilized biosensors was built on the same analyte concentration range as PrA-immobilized biosensors (from 0.001 to 1 mg / ml). Similar positive linearity was achieved for this type of biosensor with an almost doubled slope than PrA-immobilized counterparts, which was presumably due to the higher pH value of the used electrolyte rendering more negatively charged protein layers. As a result, the electrostatic repulsion to Fe(CN)s3 / 4redox probe was stronger reflecting from the higher Ret. The successful construction of two calibration lines not only signified the successful fabrication of two types of impedimetric biosensors but also confirmed the potency of the PEDOT-maleimide platform and postprocessing methods in fabricating biosensors.

[0081] Except for the desired high sensitivity, the reversibility of this impedimetric biosensor is also of interest to us specifically for economic consideration. Because PrA has a high affinity for IgG, which could crash out from the solution according to the report,1the simple incubation in lxPBS for attaining the effective protein complexes dissociation was given up at the beginning. Alternatively, 25% (v / v%) acetonitrile was chosen as it was used to successfully dissociate soluble protein complexes before. The IgG-immobilized biosensor was used in this reversibility study, and its CV and EIS were measured after each treatment to monitor the change in the electrochemical properties. 25% acetonitrile was transferred onto the biosensor after the first PrA incubation (1 mg / ml). After the acetonitrile treatment, a second PrA incubation was performed at the same concentration. The change of the CV and EIS across the whole process is compiled in FIG. 7. In FIG. 7, both CV and EIS give out the dramatic change after the first PrA sensing step which is construed as the result of the protein complexes formed between the fixed IgG and free PrA. The next incubation into 25% acetonitrile indeed brings back the redox peak current and the impedance somewhat. However, the electrochemical properties did not restore to the same level as the IgG- immobilized surface (the back color). We initially thought that partial dissociation was achieved because of the notably decreased impedance. The almost unchanged CV and EIS from the second PrA sensing step proposed that the impedance change caused by the acetonitrile treatment may be a combined effect of the denaturation of the protein layers and the partial dissociation of the protein complexes. This loss of the biosensing capability was not beyond our expectations as acetonitrile is able to denature proteins accordingly. Although the reversibility was not proven through our current dissociation approach, the decreased impedance was still a positive sign showing that the electrochemical properties could be recovered to a certain level. Our group is still working on this reversibility study by sieving the proper method.

[0082] Aside from the extensive electrochemical studies on the fabricated biosensors, XPS was also carried out to discover the change of the surface chemistries from one postprocessing step to the other. Survey scans of samples experiencing each postprocessing step are piled in FIG. 8a. As presented in FIG. 8a, in contrast to other signals, the relative intensities of N Is (yellow frame) and S 2p (blue frame) changed dynamically across the whole postprocessing procedure and the following sensing step. This was because the different chemical compositions were brought to the electrode surface at each step. For example, the click reaction with 3-MPA was reckoned to increase the atomic percentage of sulfur but decrease it of nitrogen as only one additional sulfur atom was introduced in this step. Hence, the sulfur-to-nitrogen atomic ratio was deemed to rise depending on the extent of the reaction. As the sulfur-to- nitrogen atomic ratio of PrA and IgG are extremely low, 6.9 E-3 and 2.7 E-2 respectively, the attachment of them was supposed to let the ratio of the electrode surface drop considerably. To verify this, the sulfur-to-nitrogen atomic ratios were extracted from their XPS results and shown in FIG. 8b. According to FIG. 8b, the atomic ratio first increased and then decreased after the aptamer (both PrA and IgG) immobilization. The ratio kept declining after biosensors were used for sensing trials which suggested that a thicker protein layer was formed because of the protein-protein interaction. This atomic ratio tendency revealed in FIG. 8b substantiated the successful fabrication of PEDOT-maleimide-based biosensors chemical-wise. Additionally, samples characterized in this section were electrodeposited at 7.75 E-2 C / cm2which based on our electrochemical results did not provide quantifiable EIS data (FIG. 3d). However, the XPS results clearly demonstrated the success of each postprocessing step as well as the final sensing step, like FIG. 3a, which again supported our assumption that the electrochemical techniques require the optimal thickness for gaining quantifiable EIS data. Besides, this also showed that aptamers were immobilized on PEDOT-maleimide instead of gold surface as the whole electrode was completely coated by the conductive polymer at this charge density.

[0083] To gain the morphological evolution along the postprocessing procedure and the following sensing step, samples investigated in XPS were observed under SEM subsequently. FIG. 9a presents the "peanut brittle"-like surface feature of uncoated C220 BT working electrodes comprising gold particles and high-temperature glue holding them together. After the electrodeposition of EDOT-maleimide takes place, the surface is completely coated by PEDOT-maleimide nanofibrils and the glue filled the particle gaps seen in FIG. 9a is not observable anymore with only discernible contours of those gold particles (FIG. 9b). This basically means a thick and uniform PEDOT- maleimide layer is obtained. After the observation of the drastic morphological alteration evinced by the electrodeposition, the following 3-MPA treatment, aptamer immobilization, and the final analytes sensing (FIGS. 9c-9f) essentially do not impact the morphology to the same extent as the impact on their XPS signals (FIG. 8). The same unchanged morphology of postprocessed PEDOT-maleimide was also seen in other experiments in our lab using different thiol-bearing reagents. This unchanged morphology hinted the premium structural stability of our active materials operated in the aqueous solution which is imperative for bioelectronics exposed to body fluids.

[0084] Next, for fabricating the functional OECT biosensor, apart from the chemistry examined by the impedimetric biosensor, the other imperative premise for the active material is the tunable conductivity with the change of the applied gate voltage. To characterize this, we fabricated the PEDOT-maleimide-based OECT using the IDE electrode and tested its performance following our published protocol (Lee et aL, ACS Appl. Mater. Interfaces 2022, 14 (37), 42289-42297). The corresponding output and transfer curves in FIG. 10 corroborated that the PEDOT-maleimide-based OECT possessed a high on-and-off ratio (476), and high transconductance (23.5 mS at VG = - 0.1 V vs. Ag / AgCI), which are indispensable requirements for obtaining sensitive and effective OECT biosensors. A cartoon representing the electrode configuration of this type of OECT is presented in FIG. 10c.

[0085] The same postprocessing approach discovered from the development of PrA- immobilized impedimetric biosensors was followed in fabricating OECT biosensors. The transfer curves (VD = -0.6 V) of PrA-immobilized OECT as well as its control, the one without PrA immobilization, were recorded before and after the sensing test in 1 mg / ml IgG solution. Those curves are plotted in FIGS. 11a and lib. FIG. 11a shows a noticeable shift in the transfer curve after the IgG incubation. This shift is usually ascribed to the change of the interfacial potential of the active channel materials leading by the bound charged species. Therefore, the direction and the extent of the shift are not going to be the same from one study to the other, which highly relies on the Zeta potentials of charged species and the testing condition. The shift that happened in FIG. Ila is believed to be caused by the limited physisorbed IgG on the channel material, which was also realized in our above-presented physisorption study on impedimetric biosensors (FIGS. 4d and 4h). Besides, it seems like IgG let the transfer curve shift towards the negative gate voltage direction, which should be consistent in our following examination of PrA-immobilized OECT biosensors if the PrA immobilization and IgG sensing go as what we observed in impedimetric biosensors. FIG. lib includes the same test results as with FIG. 11a, except PrA was put on the channel material this time. The displacement of the transfer curve in FIG. lib after the IgG incubation follows the same negative direction as what is shown in FIG. 11a but the shift is more visually significant. The specific interaction between PrA and IgG on PrA-immobilized OECT biosensors is accountable for this considerable change. Overall, this comparison substantiated the successful fabrication of functional OECT biosensors targeting IgG through immobilizing PrA on the PEDOT-maleimide surface adopting the discovered postprocessing procedures from our prior impedimetric biosensor studies.

[0086] Quantitatively, the largest current change before and after the IgG incubation at a certain gate voltage is 2.7 mA at 0.38 V and 9.1 mA at 0.41 V for no-PrA- and PrA- immobilized OECT biosensors, respectively. The shift of the threshold voltage is another commonly used metric to quantify the change, in that sense, the shift is -27 and -143 mV for non-PrA- and PrA-immobilized OECT biosensors, respectively. Both metrics present drastic changes from the physisorption to the specific binding cases, therefore both of them are going to be discussed and presented in our future updates to quantify the bound analytes. More specifically, the change of the threshold voltage will be focused on building the calibration line, and the drain current response will be monitored in the sequential analyte addition experiments.

[0087] As the third terminal in the general OECT system, the gate electrode can also pose a significant effect on the device's performance under the circumstance that the electrode-electrolyte interface is altered. This alteration could induce the change of the effective voltage drop across the channel materials which dictates the conductivity of the channel materials while the drain voltage remains unchanged. Therefore, the current will be impacted as a consequence, reflecting the transformation of the gate electrode interfacial environment. To demonstrate that this gate-sensing concept could work on par with the channel-sensing OECT biosensors just presented above under the proposed coating material (PEDOT-maleimide) and the corresponding postprocessing steps, the PEDOT-maleimide was plated on a gold electrode utilized as the gate terminal in an OECT system with PEDOT as the channel material. This gate- functionalized OECT biosensor follows the configuration as described in FIG. 12a. The same post-treatments were conducted on the PEDOT-maleimide coated gate electrode to endow the gate electrode capability to bind with free IgG in the solution through complexing with anchored PrA. This binding process is bound to change the current reading of the OECT biosensor as expected if it takes place near the gate electrode interface. To appropriately demonstrate the sensing capability of this gate- functionalized OECT biosensor, three IgG concentrations were carefully selected. They are 0, 0.05, and 1 mg / ml. The current level of a gate-functionalized OECT biosensor was recorded for 10 s after exposing it to IgG samples sequentially from low to high concentrations (FIG. 12b). The recording span of 10 s was chosen to ensure a stable current reading. In FIG. 12b, it is hard to differentiate the current level of the PrA immobilized biosensor (before IgG incubation) from the current level in the solution with the absence of IgG (0 mg / ml). This almost the same current level suggests that the background does not interfere with the operation of the OECT biosensor, and therefore any current change after the introduction of IgG to the current solvent system should be ascribed to the existence of IgG logically. In the wake of that the same device was incubated in 0.05 mg / ml IgG solution, and the expected current change was spotted, decreasing from around -7.12 to -6.55 mA. This current drop was recognized as proof of the sensing competence of this gate-functionalized OECT biosensor. To further test whether this sensor can respond differently to different IgG concentrations, the same device was again exposed to the IgG solution at 1 mg / ml, and indeed the decrease of its current level was captured, to 6.13 mA. So far, the differentiated current responses of the gate-functionalized OECT towards the solutions with and without IgG as well as with different IgG concentrations encourage that a working gate-functionalized OECT biosensor is achieved.

[0088] In theory, OECT biosensors are more sensitive than impedimetric biosensors and do not require the redox couple as impedimetric biosensors. Therefore, this is more convenient and suitable for in vivo applications for monitoring specific biological analytes.

[0089] All documents, books, manuals, papers, patents, published patent applications, guides, abstracts, and / or other references cited herein are incorporated by reference in their entirety. Other embodiments of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. It is intended that the specification and examples be considered as exemplary only, with the true scope and spirit of the invention being indicated by the following claims.

Claims

WHAT IS CLAIMED:

1. A method for preparing a biosensor for detecting an analyte, comprising :(a) electrodepositing a functionalized thiophene polymer on a surface of an electrode, wherein the functionalized thiophene polymer is functionalized poly(3,4- ethylenedioxythiophene) (PEDOT) or functionalized poly(3,4-propylenedioxythiophene) (PProDOT), whereby the surface is coated with the functionalized thiophene polymer;(b) adding an acid to the surface coated with the functionalized thiophene polymer, whereby the surface is coated with an acid-grafted thiophene polymer; and(c) immobilizing a biological molecule to the acid-grafted thiophene polymer via covalent binding, wherein the biological molecule is capable of forming a complex with the analyte, whereby a biosensor is prepared, wherein the biosensor comprises the electrode having the surface coated with a layer of the biological molecule- immobilized functionalized thiophene polymer.

2. The method of claim 1, wherein the functionalized thiophene polymer is PEDOT-maleimide, wherein the acid is 3-mercaptopropionic acid (3-MPA), and wherein the biological molecule is immobilized to the PEDOT-maleimide through amidation.

3. The method of claim 1, wherein the functionalized thiophene polymer is PProDOT-maleimide, wherein the acid is 3-mercaptopropionic acid (3-MPA), and wherein the biological molecule is immobilized to the PProDOT-maleimide through amidation.

4. The method of claim 2 or 3, further comprising treating the surface coated with the acid-grafted thiophene polymer with l-ethyl-3-(3- dimethylaminopropyl)carbodiimide (EDC) and N-hydroxysuccinimide (NHS) between step (b) and step (c).

5. The method of any one of claims 1-4, wherein the biological molecule is a protein.

6. The method of any one of claims 1-5, wherein the layer has a thickness of 1-1000 nm.

7. The method of any one of claims 1-6, wherein the surface in step (a) has a charge density of 1-10 E-2 C / cm2.

8. The method of claims 1-7, wherein the biosensor is an impedimetric biosensor.

9. The method of any one of claims 1-7, wherein the biosensor is an organic electrochemical transistor (OECT) biosensor comprising a gate electrode, a drain electrode, a source electrode, an organic semiconductor channel, and an electrolyte that connects the gate and channel, wherein the gate electrode is coated with the layer of the biological molecule-immobilized functionalized thiophene polymer.

10. A biosensor prepared according to the method of any one of claims 1-9.

11. A biosensor for detecting an analyte, comprising an electrode having a surface coated with a layer of a biological molecule-immobilized functionalized thiophene polymer, wherein the biological molecule-immobilized functionalized thiophene polymer comprises a biological molecule and functionalized thiophene polymer, wherein the functionalized thiophene polymer is functionalized poly(3,4- ethylenedioxythiophene) (PEDOT ) or functionalized poly(3,4-propylenedioxythiophene) (PProDOT), wherein the biological molecule is immobilized to the functionalized thiophene polymer via covalent binding and is capable of forming a complex with the analyte.

12. The biosensor of claim 11, wherein the functionalized thiophene polymer is PEDOT-maleimide.

13. The biosensor of claim 11, wherein the functionalized thiophene polymer is PProDOT-maleimide.

14. The biosensor of claim 12 or 13, and wherein the biological molecule is immobilized to the functionalized thiophene polymer through amidation.

15. The biosensor of any one of claims 11-14, wherein the layer has a thickness of 1-1000 nm.

16. The biosensor of any one of claims 11-15, wherein the biosensor is an impedimetric biosensor.

17. The biosensor of any one of claims 11-15, wherein the biosensor is an organic electrochemical transistor (OECT) biosensor comprising a gate electrode, a drain electrode, a source electrode, an organic semiconductor channel, and an electrolyte that connects the gate and channel, and wherein the gate electrode is coated with the layer of the biological molecule-immobilized functionalized thiophene polymer.

18. A method for detecting an analyte in a sample, comprising :(a) contacting the sample with the surface coated with the layer of the biological molecule-immobilized functionalized thiophene polymer in the biosensor of any one of claims 10-17; and(b) forming a complex by the analyte and the biological molecule, whereby the analyte is attached to the surface, wherein the attachment of the analyte to the surface indicates the presence of the analyte in the sample.

19. The method of claim 18, wherein the complex is formed at a pH of 6.5- 7.5.

20. The method of claim 18 or 19, further comprising removing the analyte from the surface.

Citation Information

Patent Citations

  • Preparation method of biological enzyme-loaded anode with response to enzyme by temperature stimulation

    CN108132285A

  • Carboxylic acid-modified EDOT for bioconjugation

    US20080224099A1

  • Biofunctional thiophene monomers and polymers thereof for electronic biomedical devices

    US20220289902A1

  • Polymeric films

    WO2008130326A1